NRGN and Alzheimer disease: Our meta-analysis results showed that there was no statistical difference in plasma Ng levels between AD patients with healthy control subjects (SMD: −0.252 [95% CI: −0.663 to 0.1590], z = 1.20, P = 0.230, Supplementary Fig. S3), which was consistent with their respective findings.